135 related articles for article (PubMed ID: 3005460)
1. Efficacy and specificity of human parathyroid hormone analogues as antagonists in intact clonal osteogenic sarcoma cells.
Kubota M; Ng KW; Murase J; Noda T; Moseley JM; Martin TJ
J Endocrinol; 1986 Feb; 108(2):261-5. PubMed ID: 3005460
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP-dependent and -independent effects on tissue-type plasminogen activator activity in osteogenic sarcoma cells; evidence from phosphodiesterase inhibition and parathyroid hormone antagonists.
Allan EH; Hamilton JA; Medcalf RL; Kubota M; Martin TJ
Biochim Biophys Acta; 1986 Sep; 888(2):199-207. PubMed ID: 3017447
[TBL] [Abstract][Full Text] [Related]
3. Human parathyroid hormone (PTH)-related protein and human PTH: comparative biological activities on human bone cells and bone resorption.
Fukayama S; Bosma TJ; Goad DL; Voelkel EF; Tashjian AH
Endocrinology; 1988 Dec; 123(6):2841-8. PubMed ID: 2848688
[TBL] [Abstract][Full Text] [Related]
4. Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal rat osteogenic sarcoma cell line.
Thomas DM; Rogers SD; Sleeman MW; Pasquini GM; Bringhurst FR; Ng KW; Zajac JD; Best JD
J Mol Endocrinol; 1995 Apr; 14(2):263-75. PubMed ID: 7619214
[TBL] [Abstract][Full Text] [Related]
5. Influence of the amino-terminus on in vitro and in vivo biological activity of synthetic parathyroid hormone-like peptides of malignancy.
Rabbani SA; Mitchell J; Roy DR; Hendy GN; Goltzman D
Endocrinology; 1988 Dec; 123(6):2709-16. PubMed ID: 2848683
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone degradation by chymotrypsin-like endopeptidase in the clonal osteogenic UMR-106 cell.
Yamaguchi T; Fukase M; Nishikawa M; Fujimi T; Fujita T
Biochim Biophys Acta; 1989 Feb; 1010(2):177-83. PubMed ID: 2912501
[TBL] [Abstract][Full Text] [Related]
7. Renal and adrenal adenosine 3',5'-monophosphate production and corticosteroid secretion in response to synthetic chicken parathyroid hormone-(1-34).
Rosenberg J; Pines M; Levy JJ; Nutt RF; Caulfield MP; Russell J; Sherwood LM; Hurwitz S
Endocrinology; 1989 Aug; 125(2):1082-9. PubMed ID: 2546736
[TBL] [Abstract][Full Text] [Related]
8. Cyclic adenosine 3',5'-monophosphate (cAMP)-dependent and cAMP-independent regulation of parathyroid hormone receptors on UMR 106-01 osteoblastic osteosarcoma cells.
Abou-Samra AB; Zajac JD; Schiffer-Alberts D; Skurat R; Kearns A; Segre GV; Bringhurst FR
Endocrinology; 1991 Nov; 129(5):2547-54. PubMed ID: 1718728
[TBL] [Abstract][Full Text] [Related]
9. Synthetic parathyroid hormone fragments shortened at the amino terminus stimulate glucose-6-phosphate dehydrogenase activity in the distal renal tubule.
Sakaguchi K; Fukase M; Kobayashi I; Kimura T; Sakakibara S; Katsuragi S; Morita K; Noda T; Fujita T
J Bone Miner Res; 1987 Apr; 2(2):83-90. PubMed ID: 2843002
[TBL] [Abstract][Full Text] [Related]
10. Direct modulation by estradiol of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein.
Fukayama S; Tashjian AH
Endocrinology; 1989 Jan; 124(1):397-401. PubMed ID: 2909373
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of pertussis toxin-sensitive guanyl nucleotide-binding proteins increase parathyroid hormone receptors and reverse agonist-induced receptor down-regulation in ROS 17/2.8 cells.
Abou-Samra AB; Jueppner H; Potts JT; Segre GV
Endocrinology; 1989 Nov; 125(5):2594-9. PubMed ID: 2477233
[TBL] [Abstract][Full Text] [Related]
12. Human PTH-(3-34) inhibited the effects of human parathyroid hormone-related protein on phosphate uptake in a cultured renal cell line (OK cells).
Nakai M; Fukase M; Yamaguchi T; Tsukamoto T; Fujii N; Fujita T
J Bone Miner Res; 1990 Oct; 5(10):995-1002. PubMed ID: 1964359
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone stimulation of the Na+/K+ pump in rat clonal osteosarcoma cells.
De Luise M; Harker M
J Endocrinol; 1986 Oct; 111(1):61-6. PubMed ID: 2431089
[TBL] [Abstract][Full Text] [Related]
14. Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor.
Nguyen-Yamamoto L; Rousseau L; Brossard JH; Lepage R; D'Amour P
Endocrinology; 2001 Apr; 142(4):1386-92. PubMed ID: 11250917
[TBL] [Abstract][Full Text] [Related]
15. The 7-34-fragment of human hypercalcemia factor is a partial agonist/antagonist for parathyroid hormone-stimulated cAMP production.
McKee RL; Goldman ME; Caulfield MP; DeHaven PA; Levy JJ; Nutt RF; Rosenblatt M
Endocrinology; 1988 Jun; 122(6):3008-10. PubMed ID: 2836181
[TBL] [Abstract][Full Text] [Related]
16. Identification of a monoclonal antibody which interacts with the parathyroid hormone receptor-adenylate cyclase system in murine bone.
Weinshank RL; Cain CD; Vasquez NP; Luben RA
Mol Cell Endocrinol; 1985 Jul; 41(2-3):237-46. PubMed ID: 2991044
[TBL] [Abstract][Full Text] [Related]
17. Stimulation by defined parathyroid hormone fragments of cell proliferation in skeletal-derived cell cultures.
Sömjen D; Binderman I; Schlüter KD; Wingender E; Mayer H; Kaye AM
Biochem J; 1990 Dec; 272(3):781-5. PubMed ID: 2176478
[TBL] [Abstract][Full Text] [Related]
18. Effect of 1,25-dihydroxyvitamin D3 on cyclic AMP responses to hormones in clonal osteogenic sarcoma cells.
Kubota M; Ng KW; Martin TJ
Biochem J; 1985 Oct; 231(1):11-7. PubMed ID: 2998336
[TBL] [Abstract][Full Text] [Related]
19. Binding of intact parathyroid hormone to rat osteosarcoma cells: major contribution of binding sites for the carboxyl-terminal region of the hormone.
Rao LG; Murray TM
Endocrinology; 1985 Oct; 117(4):1632-8. PubMed ID: 2992916
[TBL] [Abstract][Full Text] [Related]
20. The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor.
Behar V; Pines M; Nakamoto C; Greenberg Z; Bisello A; Stueckle SM; Bessalle R; Usdin TB; Chorev M; Rosenblatt M; Suva LJ
Endocrinology; 1996 Jul; 137(7):2748-57. PubMed ID: 8770894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
